Felbamate (Taro Pharmaceuticals U.S.A., Inc.)
Welcome to the PulseAid listing for the Felbamate drug offered from Taro Pharmaceuticals U.S.A., Inc.. This Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Taro Pharmaceuticals U.S.A., Inc. |
| NON-PROPRIETARY NAME: | Felbamate |
| SUBSTANCE NAME: | FELBAMATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
| ROUTE: | ORAL |
| DOSAGE FORM: | SUSPENSION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-06-16 |
| END MARKETING DATE: | 0000-00-00 |
Felbamate HUMAN PRESCRIPTION DRUG Details:
| Item Description | Felbamate from Taro Pharmaceuticals U.S.A., Inc. |
| LABELER NAME: | Taro Pharmaceuticals U.S.A., Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 600(mg/5mL) |
| START MARKETING DATE: | 2017-06-16 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 51672-4172_ff558824-b008-4b94-8aa5-d7818bc27a4f |
| PRODUCT NDC: | 51672-4172 |
| APPLICATION NUMBER: | ANDA206314 |
Other FELBAMATE Pharmaceutical Manufacturers / Labelers:
